Intended use: For the in vitro determination of Activated Partial Thromboplastin Time (APTT) in citrated plasma on IL Coagulation systems as a general screening procedure to evaluate the intrinsic coagulation pathway and to monitor patients receiving Heparin anticoagulant therapy.
Principle: Synthetic phospholipid preparation that includes micronized silica as activator for the determination of the APTT.
Vials and volumes:
- 5 x 9 mL APTT Reagent (liq)
- 5 x 8 mL Calcium Chloride (liq)
*ACL, ACL TOP, and HemosIL are trademarks of Instrumentation Laboratory.
Life Science Research
